NextCure Company Insiders

NXTC Stock  USD 11.92  0.73  5.77%   
NextCure's insiders are aggressively buying. The analysis of the overall insider sentiment regarding NextCure suggests that all insiders are extremely bullish. NextCure employs about 43 people. The company is managed by 12 executives with a total tenure of roughly 101 years, averaging almost 8.0 years of service per executive, having 3.58 employees per reported executive.

Insider Sentiment 100

 Aggressively Buying

 
Selling
 
Buying

Latest Trades

2019-11-15Sofinnova Venture Partners Ix,Acquired 150000 @ 36.75View
2019-05-13X L.P. CanaanAcquired 50000 @ 15View
Monitoring NextCure's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NextCure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For information on how to trade NextCure Stock refer to our How to Trade NextCure Stock guide.

NextCure's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with NextCure's future performance. Based on our forecasts, it is anticipated that NextCure will maintain a workforce of about 70 employees by February 2026.
 
Covid

NextCure Management Team Effectiveness

The company has return on total asset (ROA) of (0.5801) % which means that it has lost $0.5801 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1691) %, meaning that it created substantial loss on money invested by shareholders. NextCure's management efficiency ratios could be used to measure how well NextCure manages its routine affairs as well as how well it operates its assets and liabilities. As of January 25, 2026, Return On Tangible Assets is expected to decline to -0.83. In addition to that, Return On Capital Employed is expected to decline to -1.01. At present, NextCure's Other Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Debt To Assets is expected to grow to 0.07, whereas Total Assets are forecasted to decline to about 69.1 M.
As of January 25, 2026, Common Stock Shares Outstanding is expected to decline to about 2.3 M. In addition to that, Net Loss is expected to decline to about (70.6 M)
The market capitalization of NextCure is $41.79 Million. NextCure holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
 
Shares in Circulation  
First Issued
2019-06-30
Previous Quarter
M
Current Value
M
Avarage Shares Outstanding
M
Quarterly Volatility
344.2 K
 
Covid
Some institutional investors establish a significant position in stocks such as NextCure in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of NextCure, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

NextCure Workforce Comparison

NextCure is regarded fifth in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 419. NextCure retains roughly 43.0 in number of employees claiming about 10% of equities under Health Care industry.

NextCure Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific NextCure insiders, such as employees or executives, is commonly permitted as long as it does not rely on NextCure's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, NextCure insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2020-09-01
5.0
5
1
 105,603 
 27,229 
2019-12-01
1.5
3
2
 205,234 
 55,234 
2019-06-01
0.5806
36
62
 13,930,329 
 105,790,034 

NextCure Notable Stakeholders

A NextCure stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as NextCure often face trade-offs trying to please all of them. NextCure's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting NextCure's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
CPA CPAChief OfficerProfile
Steven CPAChief OfficerProfile
Sebastien MalovesteSenior DevelopmentProfile
Sourav KunduSenior ManufacturingProfile
Kevin ShawGeneral CounselProfile
Michael MSBACEO, CoFounderProfile
Lieping MDCoFounder BoardProfile
Timothy MayerChief OfficerProfile
MD FACPChief OfficerProfile
Udayan MDSenior DevelopmentProfile
Solomon LangermannChief OfficerProfile
Stacy RollingerVice ResourcesProfile
String symbol = request.getParameter("s");

About NextCure Management Performance

The success or failure of an entity such as NextCure often depends on how effective the management is. NextCure management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of NextCure management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the NextCure management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.79)(0.83)
Return On Capital Employed(0.96)(1.01)
Return On Assets(0.79)(0.83)
Return On Equity(0.98)(0.93)
Please note, the presentation of NextCure's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, NextCure's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of NextCure's management manipulating its earnings.

NextCure Workforce Analysis

Traditionally, organizations such as NextCure use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare NextCure within its industry.

NextCure Manpower Efficiency

Return on NextCure Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee1.3M
Net Loss Per Executive4.6M
Working Capital Per Employee1.4M
Working Capital Per Executive5.2M

Complementary Tools for NextCure Stock analysis

When running NextCure's price analysis, check to measure NextCure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NextCure is operating at the current time. Most of NextCure's value examination focuses on studying past and present price action to predict the probability of NextCure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NextCure's price. Additionally, you may evaluate how the addition of NextCure to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Equity Valuation
Check real value of public entities based on technical and fundamental data